SHARE EXCHANGE AGREEMENTShare Exchange Agreement • September 16th, 2020 • ImmunoPrecise Antibodies Ltd.
IMMUNOPRECISE ANTIBODIES LTD., a company duly formed under the laws of the Province of British Columbia, with its principal office located at Unit 3204, 4464 Markham Street, Victoria, BC V8Z 7X8
DATED 14th MARCH 2019 IMMUSYS B.V. and MODIQUEST RESEARCH B.V. and IMMULEASE B.V. and MR JOS RAATS and IMMUNOPRECISE NETHERLANDS B.V. and IMMUNOPRECISE ANTIBODIES LTD. AMENDMENT, TERMINATION AND SETTLEMENT AGREEMENTAmendment, Termination and Settlement Agreement • September 16th, 2020 • ImmunoPrecise Antibodies Ltd.
ModiQuest Research, Immulease, ImmunoPrecise Netherlands and ImmunoPrecise Antibodies are hereinafter jointly also referred to as the IPA Group Companies and each also an IPA Group Company. The IPA Group Companies, Immusys and Raats are hereinafter jointly referred to as the Parties and each as a Party.
SHAREHOLDER RIGHTS PLAN AGREEMENT BETWEEN IMMUNOPRECISE ANTIBODIES LTD. AND COMPUTERSHARE TRUST COMPANY OF CANADA Made as of October 17, 2019Shareholder Rights Plan Agreement • September 16th, 2020 • ImmunoPrecise Antibodies Ltd. • British Columbia
WHEREAS the board of directors of the Corporation has determined that it is in the best interests of the Corporation to adopt a shareholder rights plan in order to ensure, to the extent possible, that: (i) all shareholders of the Corporation are treated fairly in connection with any Offer to Acquire the outstanding Voting Shares, and (ii) the board of directors of the Corporation has the opportunity to identify, solicit, develop and negotiate value-enhancing alternatives, as appropriate, to any unsolicited Offer to Acquire the outstanding Voting Shares.
SHARE PURCHASE AGREEMENTShare Purchase Agreement • September 16th, 2020 • ImmunoPrecise Antibodies Ltd.
IMMUNOPRECISE NETHERLANDS B.V., a company duly formed under the laws of the Netherlands, with its registered office located in Haarlemmermeer, Netherlands, registered with the trade register of the Chamber of Commerce under number 71010149
